Skip to main content
placeholder image

A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2015

Citation


  • Barbour, A., O'Rourke, N., Chandrasegaram, M. D., Chua, Y. J., Kench, J., Samra, J. S., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(15_suppl), 4115. doi:10.1200/jco.2015.33.15_suppl.4115

Web Of Science Accession Number


Start Page


  • 4115

End Page


  • 4115

Volume


  • 33

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2015

Citation


  • Barbour, A., O'Rourke, N., Chandrasegaram, M. D., Chua, Y. J., Kench, J., Samra, J. S., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(15_suppl), 4115. doi:10.1200/jco.2015.33.15_suppl.4115

Web Of Science Accession Number


Start Page


  • 4115

End Page


  • 4115

Volume


  • 33

Issue


  • 15_suppl

Place Of Publication